{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T05:09:53Z","timestamp":1737781793343,"version":"3.33.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10620-024-08723-z","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T16:58:50Z","timestamp":1732899530000},"page":"386-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of Comorbidity Duration with the Occurrence and Prognosis of Steatotic Liver Disease"],"prefix":"10.1007","volume":"70","author":[{"given":"Hyunji","family":"Sang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihye","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"8723_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2023;8:20\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8723_CR2","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon TG, Roelstraete B, Khalili H, Hagstrom H, Ludvigsson JF. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut 2021;70:1375\u20131382.","journal-title":"Gut"},{"key":"8723_CR3","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","volume":"385","author":"AJ Sanyal","year":"2021","unstructured":"Sanyal AJ, Van Natta ML, Clark J et al. Prospective study of outcomes in adults with nonalcoholic fatty liver disease. N Engl J Med 2021;385:1559\u20131569.","journal-title":"N Engl J Med"},{"key":"8723_CR4","doi-asserted-by":"publisher","first-page":"s86","DOI":"10.3350\/cmh.2022.0442","volume":"29","author":"R Manikat","year":"2023","unstructured":"Manikat R, Nguyen MH. Nonalcoholic fatty liver disease and non-liver comorbidities. Clin Mol Hepatol 2023;29:s86\u2013s102.","journal-title":"Clin Mol Hepatol"},{"key":"8723_CR5","doi-asserted-by":"publisher","first-page":"1601923","DOI":"10.1183\/13993003.01923-2016","volume":"49","author":"D Viglino","year":"2017","unstructured":"Viglino D, Jullian-Desayes I, Minoves M et al. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. Eur Respir J 2017;49:1601923.","journal-title":"Eur Respir J"},{"key":"8723_CR6","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jhep.2010.11.007","volume":"54","author":"G Targher","year":"2011","unstructured":"Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol. 2011;54:1020\u20131029.","journal-title":"J Hepatol."},{"key":"8723_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","volume":"16","author":"AJ Sanyal","year":"2019","unstructured":"Sanyal AJ. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2019;16:377\u2013386.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"8723_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32499","author":"ZM Younossi","year":"2022","unstructured":"Younossi ZM, Paik JM, Al Shabeeb R et al. Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology. 2022. https:\/\/doi.org\/10.1002\/hep.32499.","journal-title":"Hepatology"},{"key":"8723_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2105\/AJPH.88.2.196","volume":"88","author":"AA Hyder","year":"1998","unstructured":"Hyder AA, Rotllant G, RH M. Measuring the burden of disease: healthy life-years. Am J Public Health 1998;88:196\u2013202.","journal-title":"Am J Public Health"},{"key":"8723_CR10","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMra1201534","volume":"369","author":"CJ Murray","year":"2013","unstructured":"Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369:448\u2013457.","journal-title":"N Engl J Med."},{"key":"8723_CR11","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","volume":"57","author":"S Zoungas","year":"2014","unstructured":"Zoungas S, Woodward M, Li Q et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia. 2014;57:2465\u20132474.","journal-title":"Diabetologia."},{"key":"8723_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000432","author":"X Zhang","year":"2023","unstructured":"Zhang X, Yip TC, Tse YK et al. Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: a landmark analysis. Hepatology. 2023. https:\/\/doi.org\/10.1097\/HEP.0000000000000432.","journal-title":"Hepatology."},{"key":"8723_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1900\/RDS.2019.15.1","volume":"15","author":"J Khateeb","year":"2019","unstructured":"Khateeb J, Fuchs E, Khamaisi M. Diabetes and lung disease: a neglected relationship. Rev Diabet Stud. 2019;15:1\u201315.","journal-title":"Rev Diabet Stud."},{"key":"8723_CR14","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33:1674\u20131685.","journal-title":"Diabetes Care."},{"key":"8723_CR15","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","volume":"112","author":"PW Wilson","year":"2005","unstructured":"Wilson PW, D\u2019Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066\u20133072.","journal-title":"Circulation."},{"key":"8723_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1053\/j.ajkd.2016.03.411","volume":"67","author":"L De Nicola","year":"2016","unstructured":"De Nicola L, Conte G, Minutolo R. Prediabetes as a precursor to diabetic kidney disease. Am J Kidney Dis. 2016;67:817\u2013819.","journal-title":"Am J Kidney Dis."},{"key":"8723_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/ije\/dyt228","volume":"43","author":"S Kweon","year":"2014","unstructured":"Kweon S, Kim Y, Jang MJ et al. Data resource profile: the Korea national health and nutrition examination survey (KNHANES). Int J Epidemiol. 2014;43:69\u201377.","journal-title":"Int J Epidemiol."},{"key":"8723_CR18","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2022021","volume":"44","author":"S Yun","year":"2022","unstructured":"Yun S, Oh K. The Korea national health and nutrition examination survey data linked cause of death data. Epidemiol Health. 2022;44:e2022021.","journal-title":"Epidemiol Health."},{"key":"8723_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.04.026","author":"YG Seo","year":"2023","unstructured":"Seo YG, Polyzos SA, Park KH, Mantzoros CS. Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population. Clin Gastroenterol Hepatol. 2023. https:\/\/doi.org\/10.1016\/j.cgh.2023.04.026.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8723_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.3346\/jkms.2016.31.8.1181","volume":"31","author":"JW Yun","year":"2016","unstructured":"Yun JW, Son M. Forecasting cause-specific mortality in Korea up to year 2032. J Korean Med Sci. 2016;31:1181\u20131189.","journal-title":"J Korean Med Sci."},{"key":"8723_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u20131986.","journal-title":"Hepatology."},{"key":"8723_CR22","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/ajg.2016.453","volume":"112","author":"S McPherson","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF et al. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017;112:740\u2013751.","journal-title":"Am J Gastroenterol."},{"key":"8723_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2146\/ajhp130492","volume":"71","author":"HS Sohn","year":"2014","unstructured":"Sohn HS, Kwon JW, Kim HS, Kim H. Implications of using cockcroft-gault and modification of diet in renal disease study equations to estimate renal function in ethnic Korean patients. Am J Health Syst Pharm. 2014;71:1009\u20131018.","journal-title":"Am J Health Syst Pharm."},{"key":"8723_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42:503\u2013508.","journal-title":"Dig Liver Dis."},{"key":"8723_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/apt.12963","volume":"40","author":"L Fedchuk","year":"2014","unstructured":"Fedchuk L, Nascimbeni F, Pais R et al. Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2014;40:1209\u20131222.","journal-title":"Aliment Pharmacol Ther."},{"key":"8723_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10462-016-9483-9","volume":"47","author":"W Altaf","year":"2016","unstructured":"Altaf W, Shahbaz M, Guergachi A. Applications of association rule mining in health informatics: a survey. Artificial Intelligence Review. 2016;47:313\u2013340.","journal-title":"Artificial Intelligence Review."},{"key":"8723_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3904\/kjim.2012.27.2.197","volume":"27","author":"HS Kim","year":"2012","unstructured":"Kim HS, Shin AM, Kim MK, Kim YN. Comorbidity study on type 2 diabetes mellitus using data mining. Korean J Intern Med. 2012;27:197\u2013202.","journal-title":"Korean J Intern Med."},{"key":"8723_CR28","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/j.ijmedinf.2009.09.005","volume":"78","author":"YM Tai","year":"2009","unstructured":"Tai YM, Chiu HW. Comorbidity study of ADHD: applying association rule mining (ARM) to national health insurance database of Taiwan. Int J Med Inform. 2009;78:e75-83.","journal-title":"Int J Med Inform."},{"key":"8723_CR29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328\u2013357.","journal-title":"Hepatology."},{"key":"8723_CR30","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O","year":"2016","unstructured":"European Association for the Study of the L, European Association for the Study of D, European Association for the Study of O. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u20131402.","journal-title":"J Hepatol."},{"key":"8723_CR31","unstructured":"Glass LM, Hunt CM, Fuchs M, Su GL. Comorbidities and nonalcoholic fatty liver disease: the chicken, the egg, or both?"},{"key":"8723_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021654","volume":"10","author":"M Fudim","year":"2021","unstructured":"Fudim M, Zhong L, Patel KV et al. Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries. J Am Heart Assoc. 2021;10:e021654.","journal-title":"J Am Heart Assoc."},{"key":"8723_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5009\/gnl19069","volume":"14","author":"AA Li","year":"2020","unstructured":"Li AA, Ahmed A, Kim D. Extrahepatic manifestations of nonalcoholic fatty liver disease. Gut Liver. 2020;14:168\u2013178.","journal-title":"Gut Liver."},{"key":"8723_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100721","volume":"5","author":"J Lim","year":"2023","unstructured":"Lim J, Sang H, Kim HI. Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease. JHEP Rep. 2023;5:100721.","journal-title":"JHEP Rep."},{"key":"8723_CR35","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.31014","volume":"71","author":"F Kanwal","year":"2020","unstructured":"Kanwal F, Kramer JR, Li L et al. Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease. Hepatology. 2020;71:808\u2013819.","journal-title":"Hepatology."},{"key":"8723_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325724","author":"TG Simon","year":"2021","unstructured":"Simon TG, Roelstraete B, Hagstrom H, Sundstrom J, Ludvigsson JF. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2021. https:\/\/doi.org\/10.1136\/gutjnl-2021-325724.","journal-title":"Gut."},{"key":"8723_CR37","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","volume":"150","author":"Z Younossi","year":"2016","unstructured":"Younossi Z, Henry L. Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality. Gastroenterology. 2016;150:1778\u20131785.","journal-title":"Gastroenterology."},{"key":"8723_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)01919-x","author":"I Lingvay","year":"2021","unstructured":"Lingvay I, Sumithran P, Cohen RV, le Roux CW. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. The Lancet. 2021. https:\/\/doi.org\/10.1016\/s0140-6736(21)01919-x.","journal-title":"The Lancet."},{"key":"8723_CR39","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41591-023-02420-6","volume":"29","author":"C Langenberg","year":"2023","unstructured":"Langenberg C, Hingorani AD, Whitty CJM. Biological and functional multimorbidity-from mechanisms to management. Nat Med. 2023;29:1649\u20131657.","journal-title":"Nat Med."},{"key":"8723_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","volume":"107","author":"G Marchesini","year":"1999","unstructured":"Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. Association of nonalcoholic fatty liver disease with insulin resistance. The American Journal of Medicine 1999;107:450\u2013455.","journal-title":"The American Journal of Medicine"},{"key":"8723_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10:284\u2013296.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"8723_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32476","author":"X Zhang","year":"2022","unstructured":"Zhang X, Wong GL, Yip TC et al. Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease. Hepatology. 2022. https:\/\/doi.org\/10.1002\/hep.32476.","journal-title":"Hepatology."},{"key":"8723_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2878","author":"C Giorda","year":"2017","unstructured":"Giorda C, Forlani G, Manti R et al. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes Metab Res Rev. 2017. https:\/\/doi.org\/10.1002\/dmrr.2878.","journal-title":"Diabetes Metab Res Rev."},{"key":"8723_CR44","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1038\/s41598-022-06205-8","volume":"12","author":"JE Han","year":"2022","unstructured":"Han JE, Shin HB, Ahn YH et al. Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus. Sci Rep. 2022;12:2538.","journal-title":"Sci Rep."},{"key":"8723_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.032","volume":"19","author":"H Yamazaki","year":"2021","unstructured":"Yamazaki H, Wang J, Tauchi S et al. Inverse association between fatty liver at baseline ultrasonography and remission of type 2 diabetes over a 2-year follow-up period. Clin Gastroenterol Hepatol. 2021;19:e555.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8723_CR46","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1136\/gut.2011.242016","volume":"60","author":"VW Wong","year":"2011","unstructured":"Wong VW, Wong GL, Yip GW et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut. 2011;60:1721\u20131727.","journal-title":"Gut."},{"key":"8723_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100320","volume":"24","author":"AE Botello-Manilla","year":"2021","unstructured":"Botello-Manilla AE, Lopez-Sanchez GN, Chavez-Tapia NC, Uribe M, Nuno-Lambarri N. Hepatic steatosis and respiratory diseases: a new panorama. Ann Hepatol. 2021;24:100320.","journal-title":"Ann Hepatol."},{"key":"8723_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/STROKEAHA.120.030433","volume":"52","author":"J Xu","year":"2021","unstructured":"Xu J, Dai L, Zhang Y et al. Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events. Stroke. 2021;52:103\u2013110.","journal-title":"Stroke."},{"key":"8723_CR49","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jhep.2021.01.045","volume":"74","author":"R Liebe","year":"2021","unstructured":"Liebe R, Esposito I, Bock HH et al. Diagnosis and management of secondary causes of steatohepatitis. J Hepatol. 2021;74:1455\u20131471.","journal-title":"J Hepatol."},{"key":"8723_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.12.022","author":"H Lee","year":"2020","unstructured":"Lee H, Lee YH, Kim SU, Kim HC. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol. 2020. https:\/\/doi.org\/10.1016\/j.cgh.2020.12.022.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"8723_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16575","author":"SA Polyzos","year":"2021","unstructured":"Polyzos SA, Kechagias S, Tsochatzis EA. Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations. Aliment Pharmacol Ther. 2021. https:\/\/doi.org\/10.1111\/apt.16575.","journal-title":"Aliment Pharmacol Ther."},{"key":"8723_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012;380:37\u201343.","journal-title":"The Lancet."},{"key":"8723_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/ajh.2009.191","volume":"23","author":"Q Gu","year":"2010","unstructured":"Gu Q, Dillon CF, Burt VL, Gillum RF. Association of hypertension treatment and control with all-cause and cardiovascular disease mortality among US adults with hypertension. Am J Hypertens. 2010;23:38\u201345.","journal-title":"Am J Hypertens."},{"key":"8723_CR54","doi-asserted-by":"publisher","first-page":"58B","DOI":"10.1016\/j.amjcard.2012.08.036","volume":"110","author":"CC Wang","year":"2012","unstructured":"Wang CC, Reusch JE. Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol. 2012;110:58B-68B.","journal-title":"Am J Cardiol."},{"key":"8723_CR55","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep4.1241","volume":"2","author":"O Shahab","year":"2018","unstructured":"Shahab O, Biswas R, Paik J et al. Among patients with NAFLD, treatment of dyslipidemia does not reduce cardiovascular mortality. Hepatol Commun. 2018;2:1227\u20131234.","journal-title":"Hepatol Commun."},{"key":"8723_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S2468-1253(23)00443-0","volume":"9","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Torp N, Johansen S et al. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study. Lancet Gastroenterol Hepatol. 2024;9:218\u2013228.","journal-title":"Lancet Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08723-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08723-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08723-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:35:25Z","timestamp":1737707725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08723-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["8723"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08723-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}